The BMA’s Controversial Stance: When Professional Bodies Get Political

The British Medical Association (BMA), the UK’s largest doctors’ union, has sparked fierce debate with recent motions that many critics say prioritize political ideology over evidence-based medicine and legal compliance. On June 25, 2025, the BMA passed a motion affirming “the right of all LGBTQ+ patients and staff to identity-based care,” appearing to challenge a recent UK Supreme Court ruling. This controversy follows earlier BMA decisions on the Israel-Palestine conflict that left Jewish doctors feeling “intimidated” and “excluded” at conferences.

BMA’s Identity Politics Clash with UK Supreme Court

The BMA’s recent motion on LGBTQ+ healthcare has placed the organization on a collision course with the UK legal system. By affirming patients’ rights to “identity-based care,” critics argue the union is deliberately challenging an April 2025 Supreme Court decision that established clear boundaries on gender identity policies.

James Esses, a prominent commentator on gender issues, didn’t mince words when addressing the motion on social media platform X: “This is in breach of the Supreme Court judgment and demonstrates the ideological capture of the BMA,” he posted, reflecting growing concern about professional bodies adopting partisan stances.

The legal implications could be serious. As user @Bird_OnA_Wire warned on X: “They aren’t [allowed to breach the ruling]. And they’ll find themselves on the end of lawsuits if they do. Plus their liability insurance will be void.” This observation isn’t merely speculative – precedent exists in cases where nurses successfully sued health trusts for implementing similar gender-identity policies that violated sex-based rights.

What’s particularly troubling to many in the medical community is the BMA resident doctors’ committee’s characterization of the Supreme Court’s ruling as “scientifically illiterate.” The committee went further, claiming that a binary sex/gender divide is “harmful and lacks medical basis” – a statement that flies in the face of established biological science recognizing sexual dimorphism as a fundamental aspect of human biology.

“If the BMA can claim a binary sex/gender divide lacks medical basis, what else did they get wrong during COVID?” asked one X user with the handle @DarlingtonUnion, highlighting how this stance undermines trust in the organization’s scientific judgment more broadly.

The controversy raises profound questions about the role of professional bodies in a democratic society. Are they bound by the same laws that govern everyone else? Or does their professional expertise grant them special status to challenge legal rulings they disagree with?

Dr. Latifa Patel, representing the BMA, defended the motion by arguing that the Supreme Court ruling doesn’t preclude healthcare that considers gender identity. “Identity-informed care ensures no patient is left behind,” she stated at the annual meeting, emphasizing disparities faced by transgender patients.

But this position appears increasingly untenable when scientific evidence is considered. Biological sex, defined by chromosomes and reproductive anatomy, remains a fundamental principle in medicine, informing everything from disease screening to drug dosages. Intersex conditions, sometimes cited to challenge the binary model, occur in only 0.05-1.7% of the population and are recognized as medical anomalies – not evidence of a sex spectrum.

X user @SplitBrainUK captured the confusion many feel about professional bodies appearing to place themselves above the law: “They are allowed to breach the ruling???!” The answer, legally speaking, is clearly no – but the BMA’s motion suggests a willingness to test those boundaries.

The BMA’s Anti-Israel Stance: A Pattern of Political Bias?

The BMA’s controversial LGBTQ+ motion isn’t occurring in isolation. It follows a pattern of politically charged decisions, most notably around the Israel-Palestine conflict, where critics argue the organization has abandoned impartiality for progressive orthodoxy.

At a recent BMA conference, five Gaza-related motions were prioritized while other international crises received no attention. The BMA’s Motion 41, which mirrors the International Holocaust Remembrance Alliance’s stance that criticism of Israel isn’t inherently antisemitic, has been criticized for creating a one-sided narrative that villifies Israel while ignoring context.

The Jewish Medical Association reported that Jewish doctors felt “intimidated, unsafe, and excluded” at the conference. This sense of marginalization was compounded by protests outside the venue that used imagery reminiscent of the Holocaust – imagery that went unchallenged by BMA leadership.

The BMA dedicated 45 motions to Gaza while completely ignoring other global crises like Sudan or Ukraine. This selective outrage raises questions about whether the organization is engaging in what some might call intellectual dishonesty – applying different standards to different conflicts based on ideological preferences rather than medical necessity or humanitarian consistency.

Motion 42, which defends healthcare professionals’ rights to criticize states for breaching international law, has been perceived as implicitly targeting Israel while ignoring documented violations by Hamas, including the use of human shields and attacks on medical facilities like the Soroka Medical Centre.

By adopting policies that appear to uncritically accept Hamas’s casualty figures and narratives, critics argue the BMA risks aligning itself with a terrorist organization’s agenda – hardly the stance one would expect from a professional medical body committed to ethical standards and evidence-based positions.

The lack of explicit protections for Jewish members who identify as Zionist or who support Israel’s right to exist suggests that the BMA’s commitment to inclusivity might be selective. This raises uncomfortable questions about whether the union truly represents all doctors impartially, or whether certain political views receive preferential treatment (fell on deaf hears).

The COVID Legacy: Trust Eroded

The BMA’s current controversies have reignited scrutiny of its role during the COVID-19 pandemic, when the organization served as a leading voice for NHS staff. While the BMA advocated for better personal protective equipment and worker protections, it also faced criticism for relying on worst-case modelling that some believe overstated risks.

X posts from 2020-2021, including from users like @DrZoeHarcombe, criticized the BMA for what some viewed as fearmongering and inconsistent messaging. Others felt the organization failed to adequately challenge government missteps, such as delays in ventilator procurement.

If the BMA is now dismissing the binary nature of biological sex—contrary to established science—it fuels doubts about its objectivity during the pandemic. As @DarlingtonUnion’s question suggests, many are wondering what other scientific facts the BMA might have gotten wrong or politically reframed.

This erosion of trust in institutions extends beyond the BMA. The same pattern of selective reporting and perceived bias appears in media coverage of complex issues, from Iran’s nuclear program to Gaza’s humanitarian crisis. For instance, UK radio station LBC’s coverage of tensions between former U.S. President Trump and intelligence officials over Iran’s nuclear capabilities omitted critical context about the significance of Iran’s 60% uranium enrichment.

This selective framing, experienced across multiple institutions and issues, has created what some call the “Gell-Mann amnesia effect” – where people forget an organization’s past errors when consuming new information from the same source. The result is a growing scepticism about institutional pronouncements, especially when they align too neatly with particular political narratives.

Can We Trust the BMA After Recent Decisions?

The fundamental question emerging from these controversies is whether the BMA remains a reliable, evidence-based medical authority, or whether it has been “captured” by a progressive mindset that prioritizes certain political positions over scientific rigor and legal compliance.

The organization’s dismissal of biological sex as binary, despite overwhelming scientific evidence, suggests ideology may be trumping medical expertise. Similarly, its apparent willingness to challenge Supreme Court rulings indicates a troubling belief that its political judgments should supersede legal authority.

The BMA’s selective focus on certain global crises while ignoring others further undermines its claims to impartiality. If an organization dedicated to medical ethics cannot apply consistent standards to humanitarian crises worldwide, how can it be trusted to provide unbiased guidance on domestic healthcare policies?

The consequences of this ideological capture extend far beyond academic debates. Medical students and practitioners who hold views contrary to the BMA’s progressive orthodoxy may feel pressured to self-censor or risk professional ostracism. Patients whose needs or concerns don’t align with the organization’s political priorities may find their care compromised or their voices ignored.

One X user summed up the frustration many feel: “They’ve made gender ideology political and now expect us to treat their pronouncements as objective medical science. How is that supposed to work?”

The Broader Pattern: Institutional Capture

The BMA’s stance reflects a broader trend of institutional capture, where bodies originally established for professional or scientific purposes gradually adopt political positions that may conflict with their stated missions.

This phenomenon isn’t limited to medical organizations. Similar patterns can be observed in media outlets like the BBC, which has faced criticism for perceived bias in coverage of issues from Brexit to transgender rights. The BBC’s approach to the Al-Ahli Hospital incident in Gaza, where initial reporting blaming Israel for an explosion was later questioned, mirrors the same selective emphasis seen in the BMA’s positions.

What makes institutional capture particularly concerning in the medical context is the field’s traditional reliance on objective evidence and scientific method. When medical bodies begin prioritizing ideology over evidence, they risk undermining the very foundation of medical practice.

The controversy also highlights a troubling double standard in how dissenting views are treated. While criticism of Israel is defended as legitimate political expression, support for Israel or questioning of progressive gender ideology is increasingly portrayed as harmful or inappropriate for medical professionals to express.

This asymmetry creates a chilling effect on debate within medical institutions. As one doctor who requested anonymity told me, “I can’t openly question certain transgender treatment protocols without risking my career, but I’m expected to accept political statements about Israel as if they’re medical consensus. That’s not science – it’s enforcement of orthodoxy.”

The Legal and Ethical Implications

The BMA’s apparent willingness to challenge a Supreme Court ruling raises serious questions about professional accountability and the rule of law. While the motion itself doesn’t explicitly violate the ruling, implementing identity-based care in ways that conflict with sex-based rights could lead to lawsuits and professional liability issues.

Beyond legal concerns, there are ethical questions about whether medical bodies should be taking political positions at all. The traditional view holds that professional organizations should focus on standards of practice, education, and advocacy for conditions that allow members to perform their work effectively – not on advancing particular political agendas.

At the same time, this controversy reveals tensions between competing ethical frameworks. The BMA defends its positions as necessary to protect vulnerable populations – transgender patients who face healthcare disparities and Palestinians suffering under conflict. Critics counter that these worthy goals don’t justify abandoning scientific rigor or adopting one-sided political narratives.

As healthcare becomes increasingly politicized, medical professionals find themselves walking an increasingly narrow tightrope. Expressing the wrong view – or sometimes any view at all – on hot-button issues can lead to professional consequences that have nothing to do with clinical competence or patient outcomes.

“We’re not allowed to discuss whether puberty blockers might harm children without being labelled transphobic,” said one paediatrician who spoke on condition of anonymity. “But somehow it’s perfectly acceptable to pass motions condemning Israel that have nothing to do with UK healthcare. Make it make sense.”

Where Do We Go From Here?

The controversy surrounding the BMA’s recent decisions reveals deep fault lines in medicine, law, and public trust. As the organization navigates these treacherous waters, it faces a critical challenge: maintaining credibility as a scientific and ethical authority while addressing the complex needs of a diverse patient population.

For medical professionals caught in these crosscurrents, the path forward isn’t clear. Many feel pressured to publicly affirm political positions they may privately question, creating a gap between professional expression and personal conviction that erodes authenticity and trust.

Patients, meanwhile, increasingly wonder whether they’re receiving care based on the best available evidence or on political considerations that may have nothing to do with their health outcomes. This uncertainty undermines the doctor-patient relationship at a time when healthcare systems already face unprecedented challenges.

The BMA’s leadership has an opportunity to bridge these divides by recommitting to evidence-based positions and political neutrality on issues beyond its core mission. This would mean acknowledging the biological reality of sex differences while still advocating for compassionate care for transgender patients, and addressing global humanitarian concerns with consistency rather than selective focus.

Without such a recalibration, the organization risks further eroding its credibility at a time when authoritative medical voices are desperately needed. The COVID-19 pandemic demonstrated both the vital importance of trusted health authorities and the devastating consequences when that trust is compromised.

As @SplitBrainUK’s question suggests, many in the medical community and the public are watching closely to see whether the BMA will prioritize political ideology or return to its roots as an organization guided by science, ethics, and the medical needs of all patients – not just those who align with particular political viewpoints.

The stakes couldn’t be higher. In an era of declining trust in institutions, the medical profession cannot afford to be seen as yet another captured territory in ongoing culture wars. Patients deserve care based on evidence, not ideology, and doctors deserve professional bodies that represent their diverse views rather than enforcing political conformity.

The BMA’s recent decisions suggest it may have lost its way. The question now is whether it can find its way back to the principles that originally made it a respected voice in British healthcare.

This post contains affiliate links. If you purchase through these links, I may earn a commission at no extra cost to you.